Terms: = Sarcomas AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Treatment
12 results:
1. Effects of zoledronic acid on osteosarcoma progression and metastasis: systematic review and meta-analysis.
Christou A; Ferreira N; Sophocleous A
Clin Exp Med; 2023 Nov; 23(7):3041-3051. PubMed ID: 36527511
[TBL] [Abstract] [Full Text] [Related]
2. Embryonal Rhabdomyosarcoma of the Uterine Cervix: A Clinicopathologic Study of 94 Cases Emphasizing Issues in Differential Diagnosis Staging, and Prognostic Factors.
Devins KM; Young RH; Ghioni M; Burandt E; Bennett JA; Oliva E
Am J Surg Pathol; 2022 Nov; 46(11):1477-1489. PubMed ID: 35941719
[TBL] [Abstract] [Full Text] [Related]
3. Morbidity and long-term results in patients with wild and mutant type Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations undergoing colorectal cancer surgery.
Aziret M; Subasi O; Bilir C; Tozlu M; Altıntoprak F; Karaman K; Ercan M; Celebi F
Ann Ital Chir; 2022; 92():65-77. PubMed ID: 35342104
[TBL] [Abstract] [Full Text] [Related]
4. Phase II Study of Pembrolizumab in Combination with Doxorubicin in Metastatic and Unresectable Soft-Tissue Sarcoma.
Livingston MB; Jagosky MH; Robinson MM; Ahrens WA; Benbow JH; Farhangfar CJ; Foureau DM; Maxwell DM; Baldrige EA; Begic X; Symanowski JT; Steuerwald NM; Anderson CJ; Patt JC; Kneisl JS; Kim ES
Clin Cancer Res; 2021 Dec; 27(23):6424-6431. PubMed ID: 34475102
[TBL] [Abstract] [Full Text] [Related]
5. Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database.
Kim YA; Cho H; Lee N; Jung SY; Sim SH; Park IH; Lee S; Lee ES; Kim HJ
Cancer Med; 2018 Dec; 7(12):6084-6092. PubMed ID: 30453386
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNA-492 overexpression exerts suppressive effects on the progression of osteosarcoma by targeting PAK7.
Song X; Xie Y; Liu Y; Shao M; Yang W
Int J Mol Med; 2017 Sep; 40(3):891-897. PubMed ID: 28677719
[TBL] [Abstract] [Full Text] [Related]
7. First ultrasound diagnosis of BI-RADS 3 lesions in young patients: Can 6-months follow-up be sufficient to assess stability?
Marcon M; Frauenfelder T; Becker AS; Dedes KJ; Boss A
Eur J Radiol; 2017 Apr; 89():226-233. PubMed ID: 28267544
[TBL] [Abstract] [Full Text] [Related]
8. Long term outcomes of patients with skull-base low-grade chondrosarcoma and chordoma patients treated with pencil beam scanning proton therapy.
Weber DC; Malyapa R; Albertini F; Bolsi A; Kliebsch U; Walser M; Pica A; Combescure C; Lomax AJ; Schneider R
Radiother Oncol; 2016 Jul; 120(1):169-74. PubMed ID: 27247057
[TBL] [Abstract] [Full Text] [Related]
9. Adult Pleomorphic Rhabdomyosarcoma: A Multicentre Retrospective Study.
Noujaim J; Thway K; Jones RL; Miah A; Khabra K; Langer R; Kasper B; Judson I; Benson C; Kollàr A
Anticancer Res; 2015 Nov; 35(11):6213-7. PubMed ID: 26504053
[TBL] [Abstract] [Full Text] [Related]
10. 18F-FDG positron emission tomography for the assessment of histological response to neoadjuvant chemotherapy in osteosarcomas: a meta-analysis.
Hongtao L; Hui Z; Bingshun W; Xiaojin W; Zhiyu W; Shuier Z; Aina H; Yuanjue S; Daliu M; Zan S; Yang Y
Surg Oncol; 2012 Dec; 21(4):e165-70. PubMed ID: 22884956
[TBL] [Abstract] [Full Text] [Related]
11. The concept of curative margin in surgery for bone and soft tissue sarcoma.
Kawaguchi N; Ahmed AR; Matsumoto S; Manabe J; Matsushita Y
Clin Orthop Relat Res; 2004 Feb; (419):165-72. PubMed ID: 15021149
[TBL] [Abstract] [Full Text] [Related]
12. [G-CSF and GM-CSF in treatment of neutropaenia after chemotherapy in children with neoplasms].
Chybicka A; Bogusławska-Jaworska J; Rosińska B; Wecławek-Tompol J; Armata J; Balcerska A; Balwierz W; Bubala H; Drabko K; Eliasinska A; Kedziora M; Sońta-Jakimczyk D; Sopylo B; Kołecki P; Kowalczyk J; Matysiak M; Rokicka-Milewska R; Stefaniak MJ; Stańczak E; Stencel D; Wysocki M; Płoszyńska A
Med Wieku Rozwoj; 2000; 4(1 Suppl 2):121-9. PubMed ID: 12021471
[TBL] [Abstract] [Full Text] [Related]
